Jim Cramer on Amgen: “Why Not Go Buy That?”

“We had Amgen connected the amusement the different day, announcing a breakthrough successful Repatha, its each different week injection squelches cholesterin to a level wherever it helps forestall bosom attacks. Why not spell bargain that?”

Photo by Yiorgos Ntrahas connected Unsplash

Amgen Inc. (NASDAQ:AMGN) delivers quality therapeutics for conditions specified arsenic cancer, cardiovascular disease, osteoporosis, and autoimmune disorders. During the November 11 episode, Cramer mentioned the banal and commented:

“If you privation to task beyond what we telephone the CPG, user packaged goods, world, I deliberation you’d bash precise good with owning J&J oregon Amgen… Amgen’s moving connected cholesterin with its Repatha injection, and it’s doing thing precise antithetic with value nonaccomplishment that could pb to terrific outcomes. They some person yields, much than 2.7%. How powerfully bash I consciousness astir these erstwhile information stocks? We person a monthly concern nine gathering connected Thursday, and I’ve told Jeff Marks, my co-portfolio manager, that we astatine slightest person to enactment 1 of these names successful the bullpen. I don’t privation to hold to look backmost and say, however did we miss that bottom?”

While we admit the imaginable of AMGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.